Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-18.13	465.23	568.23
Graham Fair Price	449.85	5.77	1.05
PEG	-98.95	0.11	-10.45
Price/Book	69.33	-39.69	-129.42
Price/Cash Flow	-20.16	72.92	91.33
Prices/Earnings	-86.55	80.29	596.75
Price/Sales	5.15	18.36	17.46
Price/FCF	-20.16	72.92	91.33
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.14	0.67	0.69
Operating Margin	91.01	0.02	0.01
ROA	766.33	0.01	< 0.005
ROE	-0.05	-0.12	-127.96
ROIC	< 0.005	0.02	527.13
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.03	-93.20
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.84	0.99	-46.46
EPS QOQ	-0.57	7.35	1187.51
FCF QOQ	0.72	0.37	-49.05
Revenue QOQ	0.03	0.04	57.21
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	12.79	12.07	-5.69
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	1.10	1.49	34.96
Quick Ratio	1.30	1.16	-10.80
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	-0.95	-3.46	-264.18
Cash	16.84	15.75	-6.46
Capex	-0.16	-0.14	12.05
Free Cash Flow	1.35	1.88	39.89
Revenue	7.04	7.48	6.22
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.36	1.23	-9.34
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	29.39	27.24	-7.31
Naive Interpretation	Member

06 - Financial Health · Weak

Rating